TIMP2 and ovarian carcinoma: Both MMP-2 and MMP-9 were enhanced in one of the ovarian cancer cell lines (SKOV3) in response to gonadotropins, while TIMP-1 and TIMP-2 were down regulated, suggesting an inverse relationship between MMPs and their endogenous inhibitors [218].